Aquestive Therapeutics, Inc. — Director's Dealing 2018

Jul 25, 2018

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Aquestive Therapeutics, Inc. (AQST)
CIK: 0001398733
Period of Report: 2018-07-24

Reporting Person: Lurker Nancy (N/A)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to purchase)	$6.54	2028-04-18	Common Stock (5078)		Direct

Footnotes

F1: This option, representing a right to purchase a total of 5,078 shares of Common Stock, was granted April 18, 2018. The shares underlying such option vest as follows: 8.33% vest on July 18, 2018 and the remaining 91.66% vest in 11 equal quarterly installments thereafter, subject in each case to Ms. Lurker's continuous service with the Issuer through the applicable vesting date.